NeuroSense Therapeutics Ltd - Warrants (09/11/2026) PEG Ratio

NeuroSense Therapeutics Ltd - Warrants (09/11/2026)'s peg ratio stands at -1.73. That is above the sector sector average of -3.76. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

NeuroSense Therapeutics Ltd - Warrants (09/11/2026) sits higher the its sector benchmark (-3.76) with a PEG ratio of -1.73. That is roughly 53.9% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

Whether -1.73 is attractive depends on NeuroSense Therapeutics Ltd - Warrants (09/11/2026)'s earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.

The history chart shows how NeuroSense Therapeutics Ltd - Warrants (09/11/2026)'s PEG ratio evolved across reporting periods, while the comparison chart places NRSNW next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.